Semax (SEM)

Synthetic peptide derived from ACTH with powerful nootropic and neuroprotective effects. Developed in Russia and approved for stroke and cognitive disorders.

Key Data

Research Status

Approved in Russia

Half-Life

Minutes (rapid absorption)

Administration

Intranasal

Typical Dosage

200-600 mcg

Mechanism of Action

Increases BDNF expression, modulates dopamine and serotonin systems, enhances neuroplasticity and NGF.

Reported Benefits

• Enhanced focus
• Memory improvement
• Neuroprotection
• Reduced anxiety
• Improved learning

All information is presented for Research Use Only (RUO). Not medical advice.